Active Ingredient(s): Adenosine
FDA Approved: * October 30, 1989
Pharm Company: * ASTELLAS
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Adenocard Overview

Adenosine is an organic compound that occurs widely in nature in the form of diverse derivatives. The molecule consists of an adenine attached to a ribose via a β-N9-glycosidic bond. Adenosine is one of four nucleoside building blocks to DNA and RNA, which are essential for all life. Its derivatives include the energy carriers adenosine mono-, di-, and triphosphate, also known as AMP/ADP/ATP. Cyclic adenosine monophosphate (cAMP) is pervasive in signal transduction. Adenosyl (Ad) is the ...

Read more Adenocard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Adenocard Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 25mg/ml, 3mg/ml
  • Solution: 60mg/20ml (3mg/ml), 90mg/30ml (3mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Adenocard: (4 results)

Sorted by National Drug Code
  • 0469-8234 Adenocard 3 mg/ml Intravenous Solution by Astellas Pharma Us, Inc.
  • 55154-8710 Adenocard 6 mg/2ml Intravenous Solution by Cardinal Health
  • 55154-8711 Adenocard 3 mg/ml Intravenous Solution by Cardinal Health
  • 61786-395 Adenocard 3 mg/ml Intravenous Solution by Remedyrepack Inc.

Other drugs which contain Adenosine or a similar ingredient: (2 results)

Related Adenocard Topics:

Have you ever had Adenocard?
Describe your experience being cardioverted with Adenocard...